Expertise in
2
conditions

Han-pin Y. Kuo

199 Tun Hwa N. Rd, 
TPQ, TW 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
199 Tun Hwa N. Rd, 
TPQ, TW 

Overview

Han-pin Kuo practices practicing medicine in Taiwan.

Kuo is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Cerebral Hypoxia, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Emphysema, and Endoscopy.

They are actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 2 clinical trials.

Locations

199 Tun Hwa N. Rd, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Drug: APL-101
Study Phase: Phase 2
A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma
A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma
Enrollment Status: Completed
Publish Date: July 09, 2026
Intervention Type: Biological
Study Drug: FB704A
Study Phase: Phase 2
View 1 Less Clinical Trial

97 Total Publications

Interpretable Machine Learning for Population-Level Tooth Loss Prediction.
Interpretable Machine Learning for Population-Level Tooth Loss Prediction.
Journal: Journal of dental research
Published: July 30, 2026

Frequently Asked Questions about Han-pin Y. Kuo

Is Han-pin Y. Kuo a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. Han-pin Y. Kuo is classified as an Advanced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Han-pin Y. Kuo participate in research or clinical trials?

Yes. Han-pin Y. Kuo has published 97 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Han-pin Y. Kuo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kuo's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile